Company news

Avita Medical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

February 12, 2025

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

January 6, 2025

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

December 22, 2024

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

December 18, 2024

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 17, 2024

AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

November 24, 2024

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

November 11, 2024

AVITA Medical Reports Third Quarter Financial Results

November 6, 2024

AVITA Medical to Announce Third Quarter 2024 Financial Results

October 9, 2024

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

September 11, 2024

AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference

September 9, 2024

AVITA Medical Reports Second Quarter Financial Results

August 7, 2024

AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales

July 31, 2024

AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care

July 30, 2024

AVITA Medical to Announce Second Quarter 2024 Financial Results

July 10, 2024

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

June 30, 2024

AVITA Medical Achieves Milestone with First Case Using RECELL GO

June 4, 2024

AVITA Medical Announces FDA Approval of RECELL GO

May 29, 2024

AVITA Medical Reports First Quarter Financial Results

May 12, 2024

AVITA Medical to Announce First Quarter 2024 Financial Results

April 14, 2024

AVITA Medical Updates Expected First Quarter 2024 Revenue

April 9, 2024

AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference

February 28, 2024

AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement

February 28, 2024

AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

February 21, 2024

AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

January 31, 2024

AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

January 9, 2024

AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

January 9, 2024

AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 3, 2024

AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference

November 20, 2023

AVITA Medical Updates Full Year 2023 Guidance

November 19, 2023

AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year

November 8, 2023

AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe

November 8, 2023

AVITA Medical to Announce Third Quarter 2023 Financial Results

October 18, 2023

AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives

October 17, 2023

AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma

September 24, 2023

AVITA Medical to Present at the Cantor Global Healthcare Conference

September 20, 2023

AVITA Medical to Participate in Upcoming Investor Conferences

September 5, 2023

AVITA Medical to Announce Second Quarter 2023 Financial Results

July 19, 2023

AVITA Medical Submits FDA PMA Supplement for RECELL GO

June 28, 2023

AVITA Medical Rejoins the Russell 3000 Index

June 25, 2023

AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients

June 15, 2023

AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer

June 14, 2023

AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects

June 6, 2023

AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance

May 10, 2023

AVITA Medical to Announce First Quarter 2023 Financial Results

April 19, 2023

AVITA Medical Announces Update to Automation Device

April 12, 2023

AVITA Medical Appoints New Non-Executive Member to the Board of Directors

March 22, 2023

AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference

March 1, 2023

AVITA Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

February 22, 2023

AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide 2023 Financial Guidance

February 8, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 55 decks. Every deck is listed under its year.